The London-based private equity firm and TA Associates are negotiating the final details of an agreement, which could be reached in the coming weeks, the people said. TA Associates has been discussing valuation of around €800 million ($828 million) for Vivacy, the people said, asking not to be identified because the matter is private.
Bridgepoint has emerged as the frontrunner for Vivacy after outbidding other buyout firms and companies in the industry, the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.